Propenidazole
From Wikipedia, the free encyclopedia
 |
|
|
Propenidazole
|
|
| Systematic (IUPAC) name | |
| ethyl (2E)-2-[(1-methyl-5-nitroimidazol-2-yl)methylidene]-3-oxobutanoate | |
| Identifiers | |
| CAS number | ? |
| ATC code | G01 |
| PubChem | |
| Chemical data | |
| Formula | C11H13N3O5 |
| Mol. mass | 267.238 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Propenidazole is an imidazole derivative used in gynecology.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||
